European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patientsEri Yamamoto, Yoshiaki Ishigatsubo, Shin Fujisawa et al.|Cancer Science|2013Cited by 39
The MAPK Erk5 is necessary for proper skeletogenesis involving a Smurf-Smad-Sox9 molecular axisTakashi Iezaki, Eiichi Hinoi, Kazuya Fukasawa et al.|Development|2018Cited by 31
Clinical Significance of Serum Ferritin at Diagnosis in Patients With Acute Myeloid Leukemia: A YACHT Multicenter Retrospective StudyTakayoshi Tachibana, Hideaki Nakajima, Taiki Andou et al.|Clinical Lymphoma Myeloma & Leukemia|2018Cited by 28
Primary Hepatic Peripheral T-Cell Lymphoma Treated with CorticosteroidKazuho Miyashita, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Internal Medicine|2011Cited by 13
Analysis of outcomes in patients with supra-diaphragmatic vs infra-diaphragmatic diffuse large B cell lymphoma treated with R-CHOP therapyYuki Nakajima, Yoshiaki Ishigatsubo, Naoto Tomita et al.|Leukemia Research|2014Cited by 12